Glaxosmithkline Pharmaceuticals Ltd

Glaxosmi. Pharma Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Glaxosmithkline Pharmaceuticals Ltd

₹ 2,210 -3.75%
29 May - close price
gsk-india.com BSE: 500660 NSE: GLAXO
About

GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people.(Source : Company Web-site)

Key Points

Leading Global Health care company[1] GlaxoSmithKline Pharmaceutical is a part of GlaxoSmithKline plc (GSK), a British multinational pharmaceutical company headquartered in London. GSK underwent a merger in 2000 of Glaxo Wellcome and SmithKline Beecham, and is the world’s sixth-largest pharmaceutical company.

Website BSE NSE
  • Market Cap ₹ 37,442 Cr.
  • Current Price ₹ 2,210
  • High / Low ₹ 3,516 / 2,194
  • Stock P/E 37.1
  • Book Value ₹ 132
  • Dividend Yield 2.58 %
  • ROCE 65.0 %
  • ROE 48.2 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 44.1%
  • Company has been maintaining a healthy dividend payout of 95.9%

Cons

  • Stock is trading at 16.7 times its book value
  • The company has delivered a poor sales growth of 5.35% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE 500 BSE Healthcare BSE 200 BSE Dollex 200 Nifty 500

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
782 738 953 805 911 811 1,000 946 966 805 974 1,023 989
615 597 667 587 656 582 681 656 635 554 639 655 642
Operating Profit 167 141 287 218 255 229 319 290 331 251 335 368 347
OPM % 21% 19% 30% 27% 28% 28% 32% 31% 34% 31% 34% 36% 35%
38 54 28 -135 32 36 37 35 39 44 34 32 36
Interest 1 0 0 0 1 0 0 0 1 0 1 1 1
Depreciation 17 16 18 17 18 16 17 19 15 16 17 20 13
Profit before tax 187 179 297 65 269 248 339 306 355 279 351 378 369
Tax % 30% 27% 27% 30% 28% 27% 27% 25% 27% 27% 27% 27% 26%
131 131 216 45 193 182 249 229 260 205 255 277 275
EPS in Rs 7.76 7.71 12.72 2.69 11.40 10.72 14.68 13.49 15.36 12.08 15.05 16.36 16.23
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 15m Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
3,288 2,826 2,903 2,872 3,129 3,225 2,920 3,218 3,216 3,407 3,723 3,790
2,660 2,349 2,482 2,361 2,522 2,566 2,323 2,462 2,417 2,507 2,553 2,490
Operating Profit 627 477 421 511 606 658 598 756 799 901 1,171 1,300
OPM % 19% 17% 14% 18% 19% 20% 20% 23% 25% 26% 31% 34%
147 125 118 69 106 -247 8 1,402 104 -20 146 145
Interest 0 0 0 0 1 6 4 2 2 2 1 3
Depreciation 25 25 27 38 49 83 79 68 66 70 67 66
Profit before tax 749 576 511 542 664 322 524 2,087 835 809 1,248 1,376
Tax % 37% 35% 34% 35% 36% 66% 32% 19% 27% 28% 26% 26%
472 375 337 352 425 110 358 1,691 608 585 919 1,012
EPS in Rs 27.84 22.11 19.88 20.78 25.11 6.50 21.11 99.79 35.88 34.51 54.25 59.73
Dividend Payout % 112% 113% 75% 84% 80% 616% 142% 90% 89% 93% 100% 95%
Compounded Sales Growth
10 Years: 3%
5 Years: 5%
3 Years: 6%
TTM: 2%
Compounded Profit Growth
10 Years: 10%
5 Years: 16%
3 Years: 20%
TTM: 17%
Stock Price CAGR
10 Years: 2%
5 Years: 8%
3 Years: 19%
1 Year: -33%
Return on Equity
10 Years: 33%
5 Years: 48%
3 Years: 44%
Last Year: 48%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 85 85 85 85 169 169 169 169 169 169 169 169
Reserves 1,767 2,120 1,944 1,995 1,973 1,671 1,328 2,508 1,584 1,615 1,780 2,072
3 2 2 1 1 0 35 20 16 19 10 33
1,382 864 991 1,884 1,766 1,291 1,565 1,925 1,559 1,745 2,142 2,000
Total Liabilities 3,236 3,071 3,021 3,965 3,909 3,132 3,097 4,623 3,328 3,548 4,101 4,275
123 204 258 325 432 758 387 331 330 321 284 281
CWIP 115 268 605 923 1,003 120 13 30 20 14 14 33
Investments 48 54 48 48 25 24 24 390 543 838 1,143 1,416
2,950 2,545 2,110 2,670 2,450 2,229 2,672 3,871 2,435 2,375 2,660 2,545
Total Assets 3,236 3,071 3,021 3,965 3,909 3,132 3,097 4,623 3,328 3,548 4,101 4,275

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
341 138 232 475 411 491 595 820 488 579 1,280 881
178 499 303 -107 -154 -63 408 -420 805 15 -37 385
-497 -638 -511 -307 -358 -428 -696 -524 -1,544 -562 -769 -737
Net Cash Flow 22 -1 25 61 -102 0 307 -124 -251 32 474 530
Free Cash Flow 178 -70 -26 641 168 336 553 2,380 455 570 1,263 828
CFO/OP 94% 72% 93% 132% 101% 103% 124% 124% 94% 92% 116% 92%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 11 16 21 19 14 11 27 23 22 24 29 26
Inventory Days 89 155 111 147 131 135 153 144 128 146 124 119
Days Payable 74 96 72 148 109 99 131 156 122 174 188 152
Cash Conversion Cycle 26 75 61 18 37 47 49 11 27 -4 -36 -7
Working Capital Days -49 25 6 -91 -72 -35 -38 -96 -59 -66 -102 42
ROCE % 41% 28% 22% 26% 31% 33% 37% 36% 36% 51% 63% 65%

Insights

In beta
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Number of Employees
Count

Log in to view insights

Please log in to see hidden values.

Login
Packs Distributed Annually
Million Packs
Manufacturing Capacity (Nashik Plant Tablets)
Billion Tablets
Market Share of Key Promoted Brands
%
Overall Industry Ranking (by value)
Rank
Daily Unit Doses Distributed
Billion Unit Doses
Number of Contract Manufacturing Units (CMOs)
Count
Unique Healthcare Professionals (HCP) Reach
Count
Number of Medical Representatives (Sales Force)
Count

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00%
2.41% 2.50% 2.93% 3.48% 4.02% 4.36% 4.50% 4.52% 4.89% 4.79% 4.63% 4.62%
10.25% 10.01% 8.64% 7.90% 7.51% 7.34% 7.30% 7.79% 7.71% 7.75% 7.70% 7.68%
0.00% 0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
12.35% 12.48% 13.42% 13.62% 13.48% 13.30% 13.21% 12.69% 12.41% 12.45% 12.67% 12.69%
No. of Shareholders 1,19,0321,15,2681,14,6631,18,9941,18,5151,19,2281,19,6251,21,8851,23,6291,22,9041,22,4601,21,763

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls